Abstract
Human chronic myelogenous leukaemia is characterized by a reciprocal translocation between chromosomes 9 and 22 resulting in an abbreviated form of chromosome 22 and the transfer of the abl cellular oncogene from chromosome 9 into the bcr gene of chromosome 22. Characterization of an 8-kilobase RNA specific to chronic myelogenous leukaemia shows it to be a fused transcript of the two genes. The fused protein that would be produced is probably involved in the malignant process.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Koeffler, P. & Golde, D. W. New Engl. J. Med. 304, 1201–1209 1269–1274 (1981).
Nowell, P. C. & Hungerford, D. A. J. natn. Cancer Inst. 25, 85–109 (1960).
Mitelman, F. & Levan, G. Hereditas 89, 207–232 (1978).
Sandberg, A.A. Cancer 46, 2221–2226 (1980).
Rowley, J. D. & Testa, J. R. Adv. Cancer Res. 36, 103–148 (1982).
Yunis, J. J. Science 221, 227–236 (1983).
Rowley, J. D. Nature 243, 290–293 (1973).
Heisterkamp, N. et al. Nature 299, 747–750 (1982).
Swan, D. C. et al. Proc. natn. Acad. Sci. U.S.A. 79, 4691–4695 (1982).
Dalla-Favera, R. et al. Science 218, 686–688 (1982).
de Kline, A. et al. Nature 300, 765–767 (1982).
Groffen, J. et al. J. exp. Med. 158, 9–15 (1983).
Gale, R. P. & Canaani, E. Proc. natn. Acad. Sci. U.S.A. 81, 5648–5652 (1984).
Heisterkamp, N. et al. Nature 306, 239–242 (1983).
Groffen, J. et al. Cell 36, 93–99 (1984).
Canaani, E. et al. Lancet i, 593–595 (1984).
Collins, S. J. et al. Science 225, 72–74 (1984).
Konopka, J. B., Watanabe, S. M. & Witte, O. N. Cell 37, 1035–1042 (1984).
Kloetzer, W. et al. Virology 140, 230–238 (1985).
Huynh, T. V., Young, R. A. & Davis, R. W. in DNA Cloning: A Practical Approach (ed. Glover, D.) (IRL, Oxford, in the press).
Goff, S. P. et al. Cell 22, 777–785 (1980).
Reddy, E. P., Smith, M. J. & Srinivason, A. Proc. natn. Acad. Sci. U.S.A. 80, 3623–3627 (1983).
Lonen, W. A. M. & Brammar, W. J. Gene 10, 249–259 (1980).
Wang, J. Y. J. et al. Cell 36, 349–356 (1984).
Blattner, F. R. et al. Science 196, 161–169 (1977).
Bender, W. et al. Science 221, 23–29 (1983).
Heisterkamp, N., Stam, K. & Groffen, J. Nature (in the press).
Todaro, G. J., Green, H. & Swift, M. R. Science 153, 1252–1255 (1966).
Wolf, D. & Rotter, V. Proc. natn. Acad. Sci. U.S.A. 82, 790–794 (1985).
Gubler, U. & Hoffman, B. J. Gene 5, 263–269 (1983).
Okayama, H. & Berg, P. Molec. cell. Biol. 2, 161–170 (1982).
Maniatis, T., Fritsch, E. F. & Sambrook, J. (eds) Molecular Cloning (Cold Spring Harbor Laboratory, New York, 1982).
Wang, J. Y. J. & Baltimore, D. Molec. cell. Biol. 3, 773–779 (1983).
Maxam, A. M. & Gilbert, W. Proc. natn. Acad. Sci. U.S.A. 74, 560–564 (1977).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Shtivelman, E., Lifshitz, B., Gale, R. et al. Fused transcript of abl and bcr genes in chronic myelogenous leukaemia. Nature 315, 550–554 (1985). https://doi.org/10.1038/315550a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/315550a0
- Springer Nature Limited
This article is cited by
-
Measurable residual disease (MRD)-testing in haematological and solid cancers
Leukemia (2024)
-
Structural mechanism of BRD4-NUT and p300 bipartite interaction in propagating aberrant gene transcription in chromatin in NUT carcinoma
Nature Communications (2023)
-
European LeukemiaNet laboratory recommendations for the diagnosis and management of chronic myeloid leukemia
Leukemia (2023)
-
Early dynamics of chronic myeloid leukemia on nilotinib predicts deep molecular response
npj Systems Biology and Applications (2022)
-
The oncogenic fusion landscape in pediatric CNS neoplasms
Acta Neuropathologica (2022)